Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!

医学 视网膜中央动脉阻塞 特奈特普酶 溶栓 纤溶剂 随机对照试验 冲程(发动机) 组织纤溶酶原激活剂 内科学 视力 外科 心肌梗塞 机械工程 工程类
作者
Oana M. Dumitrascu,Nancy J. Newman,Valérie Biousse
出处
期刊:Journal of Neuro-ophthalmology [Lippincott Williams & Wilkins]
卷期号:40 (3): 333-345 被引量:87
标识
DOI:10.1097/wno.0000000000001027
摘要

BACKGROUND: Acute nonarteritic central retinal artery occlusion (CRAO) is an eye stroke with poor visual prognosis and no proven effective therapies. Given advances in acute stroke care, thrombolysis in CRAO merits critical re-examination. We review the evidence for intravenous (IV) and intra-arterial (IA) tissue plasminogen activator (tPA) in CRAO management. EVIDENCE ACQUISITION: MEDLINE, Scopus, and Cochrane online databases were systematically searched from 1960 to present, for reports of acute IV or IA therapy with alteplase or tenecteplase in nonarteritic CRAO patients. English language case reports, case series, interventional studies, or randomized controlled trials were included. The study type, age and number of subjects, the regimen administered, the time since symptoms' onset, visual outcome, and safety reports were noted. RESULTS: Use of IV thrombolysis with alteplase was reported in 7 articles encompassing 111 patients, with 54% of them receiving IV tPA within 4.5 hours of symptom onset, and none developing symptomatic intracranial or ocular hemorrhage. Six studies described IA alteplase administration, with only 18 of a total of 134 patients (13.4%) treated within the first 6 hours after visual loss. The reported adverse events were minimal. Visual outcomes post-IV and IA thrombolysis were heterogeneously reported; however, most studies demonstrated benefit of the respective reperfusion therapies when administered very early. We found no reports of tenecteplase administration in CRAO. CONCLUSIONS: In 2020, nonarteritic CRAO patients should theoretically receive the same thrombolytic therapies, in the same time window, as patients with acute cerebral ischemia. Eye stroke and teleeye stroke code encounters must include an expert ophthalmologic evaluation to confirm the correct diagnosis and to evaluate for ocular signs that may help guide IV tPA administration or IA management. Future research should focus on developing feasible retinal penumbra imaging studies that, similar to cerebral tissue viability or perfusion imaging, can be incorporated into the thrombolysis decision-making algorithm.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
徐枘发布了新的文献求助10
刚刚
2秒前
晶晶完成签到,获得积分0
2秒前
369ninja发布了新的文献求助10
2秒前
JJBOND发布了新的文献求助10
3秒前
隐形曼青的应助被felix采纳,获得10
3秒前
Wonder罗完成签到,获得积分10
4秒前
5秒前
5秒前
xxv发布了新的文献求助10
5秒前
6秒前
CodeCraft的应助被温羞花采纳,获得10
6秒前
余香的应助被wangyongfang采纳,获得10
8秒前
Lu发布了新的文献求助10
8秒前
9秒前
9秒前
Lemon发布了新的文献求助10
9秒前
9秒前
庸人自扰发布了新的文献求助10
10秒前
方剂小于发布了新的文献求助10
11秒前
樊yuting完成签到 ,获得积分10
11秒前
12秒前
希望天下0贩的0的应助被泽北采纳,获得10
12秒前
科研通AI2S的应助被常常嘻嘻采纳,获得10
12秒前
在水一方的应助被JJBOND采纳,获得10
13秒前
坚强孤容发布了新的文献求助10
14秒前
yang发布了新的文献求助10
14秒前
布洛芬发布了新的文献求助10
14秒前
15秒前
观观完成签到 ,获得积分10
15秒前
amia发布了新的文献求助10
15秒前
15秒前
领导范儿的应助被cherish采纳,获得10
16秒前
所所的应助被ihuu采纳,获得10
17秒前
拓跋涵易发布了新的文献求助10
17秒前
完美世界的应助被11111采纳,获得10
17秒前
18秒前
Orange的应助被爱学习的大聪明采纳,获得10
19秒前
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184267
求助须知:如何正确求助?哪些是违规求助? 9573323
关于积分的说明 21830790
捐赠科研通 7781314
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480817